Drug ID:   | NPD9502 |
Drug Name:   | |
Molecular Formula:   | C8H9F3N4O4 |
Canonical SMILES:   | OC(C(F)(F)F)CN=C(Cn1ccnc1N(=O)=O)O |
Standard InCHI:   | InChI=1S/C8H9F3N4O4/c9-8(10,11)5(16)3-13-6(17)4-14-2-1-12-7(14)15(18)19/h1-2,5,16H,3-4H2,(H,13,17) |
Standard InCHIKey:   | BTLNRJMECFTISR-UHFFFAOYSA-N |
Max Developmental Stage:   | Clinical (unspecified phase) |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
Intermediate Similarity | 0.8252 | NPC332382 |
Remote Similarity | 0.6762 | NPC190949 |
Remote Similarity | 0.6095 | NPC237936 |
Remote Similarity | 0.5966 | NPC273327 |
Remote Similarity | 0.5769 | NPC327579 |
Remote Similarity | 0.5748 | NPC327613 |
Remote Similarity | 0.5667 | NPC207633 |
Remote Similarity | 0.562 | NPC187191 |
Remote Similarity | 0.562 | NPC326248 |
Molecular Weight   | 282.06 |
ALogP   | 0.7647 |
MLogP   | 1.13 |
XLogP   | 0.852 |
HDA   | 5 |
HBD   | 2 |
Rotatable Bonds   | 12 |
TPSA   | 113.78 |
RO5 Violation   | 0 |